(Q51000400)

English

The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8⁺ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848.

scientific article published on 13 July 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8⁺ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

0 references

1 reference

based on heuristic

inferred from title

author name string

Kai Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

Hui Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

Changyou Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

language of work or name

0 references

publication date

13 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

29

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

38

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

6670-6678

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Bats are natural reservoirs of SARS-like coronaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Laboratory-acquired SARS raises worries on biosafety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Disappearance of antibodies to SARS-associated coronavirus after recovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Epitope peptides and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Toll-like receptors: critical proteins linking innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Toll-like receptors and dendritic cells: for whom the bug tolls

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Mouse and human dendritic cell subtypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

Cell-mediated immunity and the challenges for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.100

7 January 2021

[The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21745520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA

1 reference

https://pubmed.ncbi.nlm.nih.gov/21745520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21745520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Role of Toll-like receptors in innate and adaptive immune responses]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21745520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2011.06.100

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/21745520

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51000400&oldid=1482321086"